Novavax | NVAX - Despesas Operacionais





Despesas Operacionais Alterar Data
Adma Biologics USD 71.95M 7.75M 2026-06
Agenus USD -199.08M 22.15M 2026-06
AstraZeneca USD 11.55B 674M 2026-09
BioCryst Pharmaceuticals USD 119.78M 673.63M 2026-06
Cassava Sciences USD 9.39M 1.78M 2026-06
Geron USD 52.07M 6.73M 2026-03
GlaxoSmithKline GBP 6.03B 227M 2026-09
MannKind USD 110.21M 690K 2026-06
Merck USD 10.75B 5.02B 2026-09
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Moderna USD 960M 817M 2026-06
Novartis USD 13.19B 3.9B 2026-09
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 89B 3.81B 2026-09
Sanofi EUR 10.51B 598M 2026-09
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06